Metformin use and prostate cancer risk Publication: Bill Preston, M. A., A. H. Riis, V. Ehrenstein, R. H. Breau, J. L. Batista, A. F. Olumi, L. A. Mucci, H. O. Adami, and H. T. Sørensen. 2014. Metformin Use and Prostate Cancer Risk.
Clinical features of leiomyosarcoma of the urinary bladder: analysis of 183 cases Publication: Bill Rodríguez, D., M. A. Preston, G. W. Barrisford, A. F. Olumi, and A. S. Feldman. 2014. Clinical Features of Leiomyosarcoma of the Urinary Bladder: Analysis of 183 Cases.
Prostate cancer in transgender women Publication: Bill Ingham, M. D., R. J. Lee, D. MacDermed, and A. F. Olumi. 2018. Prostate Cancer in Transgender Women.
Metformin: an antiproliferative agent and methylation regulator in treating prostatic disease? Publication: Bill Wang, Z., and A. F. Olumi. 2018. Metformin: an Antiproliferative Agent and Methylation Regulator in Treating Prostatic Disease?.
Expression of aromatase in tumor related stroma is associated with human bladder cancer progression Publication: Bill Wu, S., J. Ye, Z. Wang, S. X. Lin, M. Lu, Y. Liang, X. Zhu, A. F. Olumi, W. D. Zhong, and C. L. Wu. 2018. Expression of Aromatase in Tumor Related Stroma Is Associated With Human Bladder Cancer Progression.
BRCA1 Interacting Protein COBRA1 Facilitates Adaptation to Castrate-Resistant Growth Conditions Publication: Bill Yun, H., R. Bedolla, A. Horning, R. Li, H. C. Chiang, T. H. Huang, R. Reddick, A. F. Olumi, R. Ghosh, and A. P. Kumar. 2018. BRCA1 Interacting Protein COBRA1 Facilitates Adaptation to Castrate-Resistant Growth Conditions.
The Role of Lymphadenectomy in Patients with Advanced Renal Cell Carcinoma Publication: Bill Unadkat, P., A. F. Olumi, and B. Gershman. 2020. The Role of Lymphadenectomy in Patients With Advanced Renal Cell Carcinoma.
High Real-World Medication Adherence and Durable Clinical Benefit in Medicare Patients Treated with 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia Publication: Bill Zhang, H., D. M. Frendl, Z. Wang, and A. F. Olumi. 2020. High Real-World Medication Adherence and Durable Clinical Benefit in Medicare Patients Treated With 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia.
Radical prostatectomy versus external beam radiation therapy for high-grade, clinically localized prostate cancer: Emulation of a target clinical trial Publication: Bill Reitblat, C., A. Fleishman, I. A. Kaplan, K. D. Stensland, A. V. D’Amico, A. F. Olumi, A. A. Wagner, et al. 2021. Radical Prostatectomy versus External Beam Radiation Therapy for High-Grade, Clinically Localized Prostate Cancer: Emulation of a Target Clinical Trial.
Radical cystectomy versus trimodality therapy for muscle-invasive urothelial carcinoma of the bladder Publication: Bill Softness, K., S. Kaul, A. Fleishman, J. Efstathiou, J. Bellmunt, S. P. Kim, R. Korets, et al. 2022. Radical Cystectomy versus Trimodality Therapy for Muscle-Invasive Urothelial Carcinoma of the Bladder.